Design and synthesis of optimized ligands for PPAR

Details for Australian Patent Application No. 2004259000 (hide)

Owner Bethesda Pharmaceuticals, Inc.

Inventors Avery, Mitchell A.; Pershadsingh, Harrihar A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004259000

PCT Pub. Number WO2005/009437

Priority 60/489,244 21.07.03 US

Filing date 21 July 2004

Wipo publication date 3 February 2005

International Classifications

A61K 31/425 (2006.01) - Thiazoles

C07D 277/34 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009437 Priority application(s): WO2005/009437

17 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004259002-Inflatable apparatus for accessing a body cavity and methods of making

2004258998-Systems and methods for assessing disorders affecting fine motor skills using handwriting recognition